Historical record - last NADAC effective date: 1/15/2021

Product Information

REBIF 22 MCG/0.5 ML SYRINGE is a brand product labeled by EMD Serono, Inc., priced at $1400.9343 per ML under NDC 44087002203. Its NADAC has been published 417 times since Jan 22, 2014.

REBIF 22 MCG/0.5 ML SYRINGE

INTERFERON BETA-1A
$1400.9343per ML

Strength

22 ug/.5mL

Manufacturer

EMD Serono, Inc.

NDC

44087002203

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

1/15/2021

Active Ingredients

INTERFERON BETA-1A

Approval Type

Biologic (BLA)

FDA Application

BLA103780

On Market Since

3/7/2002

Pharmacological Classes

Interferon beta
Interferon-beta

Price Statistics

The NADAC for REBIF 22 MCG/0.5 ML SYRINGE has been published 417 times since Jan 22, 2014, and over the history we have for it it has risen 83.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1400.9343 per ML
All-time high$1400.9343 (Jan 12, 2022)
All-time low$763.5440 (Jan 22, 2014)
Median price$1085.2981
Average price$1094.2365
Largest weekly change+7.0% (Oct 15, 2014)
Weeks tracked417
Tracking sinceJan 22, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

0.0%

All

+83.5%

Last surveyed Jan 12, 2022 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the INTERFERON BETA-1A market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of REBIF 22 MCG/0.5 ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for REBIF 22 MCG/0.5 ML SYRINGE, manufactured by EMD Serono, Inc., is $1400.9343 per ML (NDC 44087002203), effective Jan 12, 2022.

How has the price of REBIF 22 MCG/0.5 ML SYRINGE changed over time?

Over the history we have for it, the NADAC for REBIF 22 MCG/0.5 ML SYRINGE has risen 83.5%. It has been tracked across 417 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for REBIF 22 MCG/0.5 ML SYRINGE?

Since Jan 22, 2014, the NADAC for REBIF 22 MCG/0.5 ML SYRINGE has ranged from a low of $763.5440 (Jan 22, 2014) to a high of $1400.9343 (Jan 12, 2022), with a median of $1085.2981 per ML.

Are there cheaper alternatives to REBIF 22 MCG/0.5 ML SYRINGE?

No other NADAC-published product currently shares the active ingredient and strength of REBIF 22 MCG/0.5 ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures REBIF 22 MCG/0.5 ML SYRINGE?

REBIF 22 MCG/0.5 ML SYRINGE (NDC 44087002203) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.